Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Traws Pharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
TransCode Therapeutics Inc. July 20, 202696.1%
-
Traws Pharma Inc. July 8, 202687.3%
-
Traws Pharma Inc. November 21, 202598.4%
-
Traws Pharma Inc. October 29, 202499.2%
-
Profusa Inc. March 21, 2024100.0%
-
Traws Pharma Inc. August 10, 202380.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Profusa Inc. | Other | +32,018 | — | — |
| Aug 21, 2026 | Profusa Inc. | Other | −301,991 | — | — |
| Aug 12, 2026 | Profusa Inc. | Derivative conversion | +301,991 | $4.28 | $1,292,521 |
| Jan 26, 2026 | Profusa Inc. | Other | +553,665 | — | — |
| Dec 12, 2025 | Traws Pharma Inc. | Grant or award | +6,157 | — | — |
Questions about Jack E. Stover
What boards is Jack E. Stover on?
Jack E. Stover sits on the boards of Profusa Inc., TransCode Therapeutics Inc. and Traws Pharma Inc.
How long has Jack E. Stover served on boards?
Our records show at least 5 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.